Fang Chen

CRISPR-engineered T cells in patients with refractory cancer

Howard Y. Chang, Wei-Ting Hwang, Frederic D Bushman, 2020, Science.

Determinants of response and resistance to CD19 chimeric antigen receptor (CAR) T cell therapy of chronic lymphocytic leukemia

Hans Bitter, Wei-Ting Hwang, Iulian Pruteanu-Malinici, 2018, Nature Medicine.

Deep immune profiling of COVID-19 patients reveals distinct immunotypes with therapeutic implications

Sasikanth Manne, John P. Reilly, Allison R. Greenplate, 2020, Science.

Ruxolitinib Prevents Cytokine Release Syndrome after CART Cell Therapy without Impairing the Anti-Tumor Effect in a Xenograft Model

Carl H. June, C. June, J. Melenhorst, 2016 .

Deep immune profiling of COVID-19 patients reveals patient heterogeneity and distinct immunotypes with implications for therapeutic interventions

Sasikanth Manne, John P. Reilly, Allison R. Greenplate, 2020, bioRxiv.